Market Research Logo

Botanical and Plant-Derived Drugs Market Forecast to 2027

Botanical and Plant-Derived Drugs Market Forecast to 2027

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures– all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Botanical and Plant-derived Drugs Market forecast to 2027
  • This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
  • Steroids
  • Phenols
  • Terpenes
  • Glycosides
  • Others
This report provides a SWOT analysis for each submarket.
  • This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
  • Hormone Diseases
  • Infectious Diseases
  • Pain & Central Nervous System Disorders
  • Cardiovascular & Metabolic Diseases
  • Respiratory & Oncology Diseases
  • Our work also shows individual revenue forecasts to 2027 for these regional and national markets
  • North America: US & Canada
  • Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, Japan, India, Rest of APAC
  • Latin America: Brazil, Mexico, Rest of Latin America
  • Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa
Each regional market if further segmented by type and by application.
  • This report discusses several brands, including:
  • Sativex (GW Pharmaceuticals)
  • Marinol (Unimed Pharmaceuticals)
  • Nabilone / Cesamet (Valeant Pharmaceuticals)
  • Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
  • CT-3 (Indevus Pharmaceuticals)
  • Cannabinor (Pharmos)
  • HU 308 (Pharmos)
  • HU 331 (Cayman Chemical)
  • Rimonabant / Acomplia (Sanofi-Aventis)
  • Taranabant / MK-0364 (Merck & Co.)
  • This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Bristol-Myers Squibb (BMS)
  • Medigene AG
  • This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Global Botanical and Plant-Derived Drugs Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Botanical and Plant-Derived Drugs Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Botanical and Plant-Derived Drugs
2.1 An Introduction to Botanical and Plant-Derived Drugs
2.2 Plants with Antidiabetic Activity
2.3 Plants with Anticancer Activity
2.4. Steroids
2.5. Phenols
2.6. Terpenes
2.7 Glycosides
2.8. Drivers
2.8.1. Increasing prevalence of various chronic diseases
2.8.2. Cost effective
2.8.3. Increasing Investment in botanical and plant-derived drugs
2.9. Restrains
2.9.1 Stringent laws and regulations for approval of botanical drugs
2.10. Regulation
3. Global Botanical and Plant-Derived Drugs Market 2017-2027
3.1 Global Botanical and Plant-Derived Drugs Market Forecast 2017-2027
3.2 Changing Market Shares by Segment 2017-2027
3.3 Global Steroids Segment Market: Sales Forecast 2017-2027
3.3.1. SWOT Analysis of the Steroids Market, 2017-2027
3.3.1.1.1. Physical Strength and Stamina
3.3.1.2. Weakness
3.3.1.2.1. Risk of Cardiovascular Diseases
3.3.1.3. Opportunity
3.3.1.3.1. Increasing popularity
3.3.1.4. Threat
3.3.1.4.1. Steroids are considered as illegal
3.4 Global Phenols Segment Market: Sales Forecast 2017-2027
3.4.1. SWOT Analysis of the Phenols Market, 2017-2027
3.4.1.1. Strength
3.4.1.1.1. Control of diseases
3.4.1.1.2. Cost Effective
3.4.1.2. Weakness
3.3.1.2.1. Hazardous Waste
3.4.1.3. Opportunity
3.4.1.3.1. Increasing prevalence of cancer
3.4.1.4. Threat
3.4.1.4.1. Side Effects
3.5 Global Terpenes Segment Market: Sales Forecast 2017-2027
3.5.1. SWOT Analysis of the Terpenes Market, 2017-2027
3.5.1.1. Strength
3.5.2.1.1. Terpenoids may be used in combination with other chemotherapeutic drugs
3.5.1.2. Weakness
3.5.1.2.1. Synergistic Effects
3.5.1.3. Opportunity
3.5.1.3.1. Increasing Prevalence of Cancer
3.5.1.4. Threat
3.5.1.4.1. Side effects
3.6 Global Glycosides Segment Market: Sales Forecast 2017-2027
3.6.1. SWOT Analysis of the Glycosides Market, 2017-2027
3.6.1.1. Strength
3.6.1.1.1. Glycosides are one of the leading methods of curing heart disease
3.6.1.2. Weakness
3.6.1.2.1. Overdose of glycosides causes serious health problems
3.6.1.3. Opportunity
3.6.1.3.1. Increasing prevalence of Heart Diseases
3.6.1.4. Threat
3.6.1.4.1. Side Effects
3.7 Global Others Segment Market: Sales Forecast 2017-2027
3.8 Global Botanical and Plant-Derived Drugs Market: Brand
3.8.1. Sativex (GW Pharmaceuticals)
3.8.2. Marinol (Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals)
3.8.3. Nabilone / Cesamet (Valeant Pharmaceuticals International)
3.8.4. Dexanabinol (Solvay Pharmaceuticals acquired by Abbott Laboratories)
3.8.5. CT-3 (ajulemic acid) (Indevus Pharmaceuticals)
3.8.6. Cannabinor (Pharmos)
3.8.7 HU 308 (Pharmos)
3.8.8 HU 331 (Cayman Chemical)
3.8.9 Rimonabant / Acomplia (Sanofi-Aventis)
3.8.10 Taranabant / MK-0364 (Merck and Co.)
4. Global Botanical and Plant-Derived Drugs Market, by Application: Sales Forecast 2016-2027
4.1 Changing Market Shares by Sub-Segment, 2017-2027
4.2 Global Hormone Diseases Segment: Sales Forecast 2016-2027
4.3 Global Infectious Diseases Segment: Sales Forecast 2016-2027
4.4 Global Pain & Central Nervous System Disorders Segment: Sales Forecast 2016-2027
4.5. Global Cardiovascular & Metabolic Diseases Segment: Sales Forecast 2016-2027
4.6 Global Respiratory & Oncology Diseases Segment: Sales Forecast 2016-2027
5.Leading National Markets 2017-2027
5.1.Geographical Breakdown of the World Botanical and Plant-Derived Drugs Market
5.2 World Botanical and Plant-Derived Drugs Market: Regional Forecast 2017-2027
5.2.1 How Will Regional Market Shares Change to 2027?
6. North America Botanical and Plant-Derived Drugs Market 2017-2027
6.1. U.S. Botanical and Plant-Derived Drugs Market: Trends and Developments
6.2. Canada Botanical and Plant-Derived Drugs Market: Trends and Developments
7. Europe Botanical and Plant-Derived Drugs Market 2017-2027
7.1. Germany Botanical and Plant-Derived Drugs Market Forecast 2017-2027
7.2. France Botanical and Plant-Derived Drugs Market Forecast 2017-2027
7.3. U.K. Botanical and Plant-Derived Drugs Market Forecast 2017-2027
7.4. Italy Botanical and Plant-Derived Drugs Market Forecast 2017-2027
7.5. Spain Botanical and Plant-Derived Drugs Market Forecast 2017-2027
7.6. Rest of Europe Botanical and Plant-Derived Drugs Market Forecast 2017-2027
8. Asia Pacific Botanical and Plant-Derived Drugs Market 2017-2027
8.1. China Botanical and Plant-Derived Drugs Market: Trends and Developments
8.2. Japan Botanical and Plant-Derived Drugs Market: Trends and Developments
8.3. India Botanical and Plant-Derived Drugs Market: Trends and Developments
8.4. Rest of Asia Pacific Botanical and Plant-Derived Drugs Market: Trends and Developments
9. Latin America Botanical and Plant-Derived Drugs Market 2017-2027
9.1 Brazil Botanical and Plant-Derived Drugs Market: Trends and Developments
9.2. Mexico Botanical and Plant-Derived Drugs Market: Trends and Developments
9.3. Rest of Latin America Botanical and Plant-Derived Drugs Market: Trends and Developments
10. Middle East and Africa Botanical and Plant-Derived Drugs Market 2017-2027
10.1. Saudi Arabia Botanical and Plant-Derived Drugs Market Forecast 2017-2027
10.2. South Africa Botanical and Plant-Derived Drugs Market Forecast 2017-2027
10.3. Rest of Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast 2017-2027
11. Leading Companies in the Botanical and Plant-Derived Drugs Market
11.1. Abbott Laboratories
11.1.1 Abbott Laboratories: Botanical and Plant-Derived Drugs Product Portfolio
11.1.2 Financial Overview
11.1.3 Recent Transactions Summary
11.2. Bayer AG
11.2.1 Bayer AG: Botanical and Plant-derived Drugs Portfolio
11.2.2 Financial Overview
11.2.3 Recent Transactions Summary
11.3. Eli Lilly and Company
11.3.1 Eli Lilly and Company: Botanical and Plant-derived Drugs Portfolio
11.3.2 Financial Overview
11.3.3 Recent Transactions Summary
11.4. Johnson & Johnson
11.4.1. Johnson & Johnson: Botanical and Plant-Derived Drugs Portfolio
11.4.2 Financial Overview
11.4.3.Recent Transactions Summary
11.5. Novartis AG
11.5.1 Novartis: Botanical and Plant-Derived Drugs Product Portfolio
11.5.3 Novartis: Recent Developments
11.6. Pfizer, Inc.
11.6.1 Pfizer, Inc.: Botanical and Plant-Derived Drugs Portfolio
11.6.2 Pfizer, Inc.: Financial Overview
11.6.3 Pfizer, Inc.: Recent Developments
11.7. Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb: Botanical and Plant-derived Drugs Portfolio
11.7.2 Bristol-Myers Squibb: Financial Overview
11.7.3 Bristol-Myers Squibb: Recent Developments
11.8. Medigene AG
11.8.1 Medigene AG: Botanical and Plant-derived Drugs Portfolio
11.8.2 Medigene AG: Financial Overview
11.8.3 Medigene AG: Recent Developments
12. Conclusions
12.1 The World Botanical and Plant-derived Drugs Market in 2016 and 2017
12.1.1 Current Leading Botanical and Plant-derived Drugs Segments
12.1.2 Leading Regional Markets
12.2 World Botanical and Plant-derived Drugs Market Forecast 2017-2027
12.3 The Future of the Botanical and Plant-derived Drugs Market?
Table of Tables
Table 2.1 Some Plants having Hypoglycemic Activity
Table 2.2 List of Herbs Commonly Used in Cancer Treatment
Table 3.1 Global Botanical and Plant-Derived Drugs Market by Product Type: Revenue ($m) and Market Share (%), 2016
Table 3.2 Global Botanical and Plant-Derived Drugs Market Forecast, By Types of Plant Drugs: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.3 Global Steroids Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.4 SWOT Analysis of the Steroids Market, 2017-2027
Table 3.5 Global Phenols Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.6 SWOT Analysis of the Phenols Market, 2017-2027
Table 3.7 Global Terpenes Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.8 SWOT Analysis of the Terpenes Market, 2017-2027
Table 3.9 Global Glycosides Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.10 SWOT Analysis of the Glycosides Market, 2017-2027
Table 3.11 Global Others Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.1 Global Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.2 Global Hormone Diseases Segment Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.3 Global Infectious Diseases Segment Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.4 Global Pain & Central Nervous System Disorders Segment Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.5 Global Cardiovascular & Metabolic Diseases Segment Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.6 Global Respiratory & Oncology Diseases Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.1 Global Botanical and Plant-Derived Drugs Market by Region: Revenue ($m), 2016 and 2017
Table 5.2 Global Botanical and Plant-Derived Drugs Market Forecast, by Region: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.1 North America Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.2 North America Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.3 North America Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 6.4 US Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 6.5 Canada Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 7.1 Europe Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.2 Europe Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.3 Europe Botanical and Plant-Derived Drugs Market Forecast, By Country: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.4 Germany Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 7.5 France Botanical and Plant-Derived Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.6 U.K. Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 7.7 Italy Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 7.8 Spain Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 7.9 Rest of Europe Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 8.1 Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 8.2 Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 8.3 Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 8.4 China Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 8.5 Japan Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 8.6 India Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 8.7 Rest of Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 9.1 Latin America Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 9.2 Latin America Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 9.3 Latin America Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 9.4 Brazil Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 9.5 Mexico Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 9.6 Rest of Latin America Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 10.1 Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 10.2 Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 10.3 Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, by Country 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 10.4 Saudi Arabia Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 10.5 South Africa Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 10.6 Rest of MEA Botanical and Plant-Derived Drugs Market Forecast, 2016-2027 ($m, AGR %, CAGR %, Cumulative)
Table 11.1 Abbott Laboratories: Overview, 2017
Table 11.2 Abbott Laboratories: Revenue ($m), AGR (%), 2012-2016
Table 11.3 Bayer AG: Overview, 2017
Table 11.4 Bayer AG: Revenue ($m), AGR (%), 2012-2016
Table 11.5 Eli Lilly and Company: Overview, 2017
Table 11.6 Eli Lilly and Company: Revenue ($m), AGR (%), 2012-2016
Table 11.7. Johnson & Johnson: Overview, 2017
Table 11.8 Johnson & Johnson: Revenue ($m), AGR (%), 2012-2016
Table 11.9 Novartis: Overview, 2017
Table 11.10 Novartis: Revenue ($m), AGR (%), 2012-2016
Table 11.11 Pfizer, Inc.: Overview, 2017
Table 11.12 Pfizer, Inc.: Revenue ($m), AGR (%), 2011-2015
Table 11.13 Bristol-Myers Squibb: Overview, 2017
Table 11.14 Bristol-Myers Squibb: Revenue ($m), AGR (%), 2012-2016
Table 11.15 Medigene AG: Overview, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report